March 27, 2013. The Office of the Inspector General has issued a special fraud alert, warning patients about doctors who also own businesses that sell medical devices that those physicians may then implant in their patients.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA Advisors Vote Against Two Drugs for Menopausal Hot Flashes
Reuters, March 5, 2013. Advisers to the Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause. “The FDA’s advisors did a great job today of carefully considering the scientific evidence,” said Diana Zuckerman, president of the National Research Center for Women & Families.
Read More »Hip Implants a Bit More Likely to Fail in Women
Associated Press, February 18, 2013. A new study reports that hip replacements are slightly more likely to fail in women than in men. Dr. Zuckerman states, “this is the first step in what has to be a much longer-term strategy to figure out why women have worse experiences.”
Read More »Study Suggests Women Have Higher Risk of Hip Implant Failure
The JAMA Network, February 18, 2013. A study in JAMA shows that women have a higher risk of implant failure than men following total hip replacement. In a commentary, NRC President Diana Zuckerman stresses that long-term comparative effectiveness data would enable patients and their physicians to choose the hip devices and surgical techniques that are most likely to be successful for a longer period.
Read More »Metal Hip Implants Face Tighter Controls
Wall Street Journal, January 18, 2013. Diana Zuckerman, president of the National Research Center for Women & Families, said: “There are so many shortcuts at the FDA device center that they often take a shortcut and approve a product with minimal safety testing.”
Read More »